Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Furosemide artificial antigen, antibody and application of antibody in detection of furosemide

An artificial antigen, furosemide technology, applied in the direction of biological testing, measuring devices, material inspection products, etc.

Active Publication Date: 2020-12-29
SOUTH CHINA AGRI UNIV
View PDF7 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Immunological detection has the characteristics of rapidity and simplicity, and the key to the establishment of the above method is to design a suitable artificial antigen for furosemide and obtain an antibody with high sensitivity and strong specificity. Related reports on rice artificial antigen and antibody

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Furosemide artificial antigen, antibody and application of antibody in detection of furosemide
  • Furosemide artificial antigen, antibody and application of antibody in detection of furosemide
  • Furosemide artificial antigen, antibody and application of antibody in detection of furosemide

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0041] Synthesis and identification of embodiment 1 furosemide immunogen

[0042] 1, the synthetic method of furosemide immunogen

[0043] Using 2,4-dichloro-5-sulfonamidobenzoic acid as a hapten, INN1-conA was synthesized by coupling soybean protein (conA) through the active ester method. The synthetic route is as follows figure 1 shown.

[0044](1) Accurately weigh 2 mg of 2,4-dichloro-5-sulfonamidobenzoic acid, dissolve 1 mg of NHS and 2 mg of EDC in 150 μL DMF, and stir for 4 hours at room temperature in the dark to obtain INN1 activation solution;

[0045] (2) Add 10mg of soybean protein (conA) to 1mL of PBS buffer (0.01moL / L, pH=7.4);

[0046] (3) Slowly add the INN1 activation solution to the conA solution drop by drop, and react at 4°C for 12 hours;

[0047] (4) Dialyze with PBS buffer for two days, 4 times a day. After the dialysis, dilute the protein solution to 2ml to obtain a 5mg / ml protein conjugate, namely furosemide immunogen INN1-conA, which is packed in a c...

Embodiment 2

[0052] Synthesis and identification of embodiment 2 furosemide coating former

[0053] 1. Cationicization of carrier protein

[0054] (1) Weigh 0.675g bovine serum albumin BSA (0.015mmol) and 56mg ethyl-[3-(dimethylamino)propyl]carbodiimide (EDC) (0.3mmol) and dissolve in 20mL PBS buffer (0.01moL / L, pH 7.4), placed on a magnetic stirrer and stirred at room temperature for 30min to fully dissolve;

[0055] (2) Slowly add the above-prepared buffer into 20 mL of PBS buffer (0.01 moL / L, pH 7.4) dissolved with 18 mg of ethylenediamine (0.3 mmol), and place on a magnetic stirrer and stir at room temperature for 120 min;

[0056] (3) Transfer the prepared mixed solution to a dialysis bag, use PBS buffer solution (0.01moL / L, pH 7.4) as the dialysate, place it at 4°C for 3 days with stirring and dialyze, and replace the dialysate every 6 hours, Centrifuge the dialyzed solution at 4000r / min, 4°C for 30min to remove excess ethylenediamine, collect the supernatant and lyophilize, the wh...

Embodiment 3

[0066] Example 3 Preparation of Furosemide Polyclonal Antibody

[0067] The prepared immunogen INN1-CONA was evenly emulsified with an equal amount of immune adjuvant (incomplete Freund's adjuvant was used for the first immunization, and incomplete Freund's adjuvant was used for subsequent booster immunizations), and animals were immunized. The 2.5-3kg New Zealand white rabbits were immunized by subcutaneous injections on the back, subcutaneous injections in various parts, leg muscles and ear veins respectively. The second immunization was done after 4 weeks, and the booster immunization was performed every 3 weeks thereafter. One week after the third booster immunization, blood was collected from the ear vein, and the serum titer was determined by indirect competitive ELISA. When the titer no longer rises, the ear vein is used to boost the immunization. One week later, blood was collected from the heart, bathed in water for 0.5-1 hour, centrifuged at 4°C and 10,000 rpm for 1...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a furosemide artificial antigen, an antibody and application of the antibody in detection of furosemide. The furosemide artificial antigen is obtained by coupling carrier protein to carboxyl of 2, 4-dichloro-5-sulfamoylbenzoic acid; the antibody is obtained by immunizing an animal with the furosemide artificial antigen. The artificial antigen is prepared by taking the 2, 4-dichloro-5-sulfamoylbenzoic acid as a specific hapten structure to replace an analysis object furosemide; the animal is immunized to obtain the high-specificity furosemide antibody, the lowest detection limit of the antibody to the furosemide is 0.58ng / mL, and the half-inhibition concentration is 12.6ng / mL; and an immune rapid detection method for the furosemide in health food is established, thebreakthrough of rapidly detecting the furosemide in the health food is achieved, and the furosemide artificial antigen has great significance in safety supervision of illegally added drugs in weight-losing health food.

Description

technical field [0001] The invention relates to the technical field of food safety detection, and more specifically relates to a furosemide artificial antigen, antibody and application thereof in the detection of furosemide. Background technique [0002] Furosemide (INN), also known as 4-chloro-2-[(2-furylmethyl)-amino]-5-sulfamoylbenzoic acid, belongs to BCS IV drugs. It is a loop diuretic, and its mechanism of action is mainly to accelerate or inhibit cell metabolism by changing the activity of related enzymes in the kidney or the permeability of the cell membrane, thereby accelerating the excretion of water in the body. In the medical field, it is usually used to treat edema, congestive heart failure, renal failure and high blood pressure. However, symptoms such as vomiting, dizziness, weakness, renal function damage, hypokalemia, etc. may occur in severe cases life threatening. In recent years, driven by profit, some unscrupulous merchants have taken risks and illegall...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07K14/415C07K14/765C07K16/44C07K16/06C07K1/30G01N33/558G01N33/543G01N33/535
CPCC07K14/415C07K14/765C07K16/065C07K16/44G01N33/535G01N33/54346G01N33/558G01N33/94
Inventor 雷红涛黎莹莹沈兴李向梅李兆栋林建浩王锦陈佳虹孙远明
Owner SOUTH CHINA AGRI UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com